Business · 05/09/2008Updated: 10/17/2026 · 1 min read
FDA Publishes Bioequivalence Recommendations for Industry
Summary
The FDA has released additional draft and revised draft product-specific bioequivalence recommendations to support abbreviated new drug applications, providing guidance on designing BE studies for specific products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →